Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Melanoma Set to Be a Hot Topic at ASCO
WSJ Online
Wednesday, June 1, 2011 - 12:35pm
tags:
ASCO, melanoma, skin cancer, Yervoy, Bristol-Myers Squibb, Daiichi Sankyo, Roche
One Reason the Street Should Love Abbott Laboratories' Earnings
Motley Fool
Wednesday, June 1, 2011 - 10:32am
tags:
earnings, Abbott Laboratories
Novo Will Boost China Investments to Fend Off Sanofi, COO Says
Bloomberg
Wednesday, June 1, 2011 - 8:26am
tags:
China, Sanofi, Novo Nordisk
FDA Reviews Clot Risks Of Bayer Birth Control Pills
Pharmalot
Wednesday, June 1, 2011 - 8:06am
tags:
Bayer, birth control pill, drospirenone, blood clots
Bausch & Lomb to introduce eye care products in India
Pharmaceutical Business Review
Wednesday, June 1, 2011 - 8:03am
tags:
India, Bausch & Lomb
South Carolina AG Sues Glaxo Over Avandia
Pharmalot
Wednesday, June 1, 2011 - 8:01am
tags:
South Carolina, GSK, diabetes, lawsuits, Avandia
Pfizer May Cut Loose Its Generics Unit Despite Doubts It Can Thrive on Its Own
BNET Pharma
Wednesday, June 1, 2011 - 7:56am
tags:
Pfizer, generics, reorganization, Greenstone
Novartis Eyes Consumer, Veterinary Purchases Up to $3 Billion
Bloomberg
Wednesday, June 1, 2011 - 7:54am
tags:
animal health, M&A, Novartis
Biotech billionaire raises $100M for synthetic biology venture Intrexon
Fierce Biotech
Wednesday, June 1, 2011 - 7:53am
tags:
Intrexon
5 Biotechs With Upcoming Clinical Trial Results
Motley Fool
Wednesday, June 1, 2011 - 7:52am
tags:
Amarin, AMR101, cabozantinib, Exelixis, HIV quad pill, Gilead Sciences, Medivation, MDV3100, Astellas, Vical, skin cancer, YM BioSciences, nimotuzumab
Pfizer says it asked European Union to approve its kidney cancer drug candidate axitinib
Yahoo/AP
Wednesday, June 1, 2011 - 7:49am
tags:
kidney cancer, Pfizer, Europe, Axitinib
Pozen sues, saying patent infringed
Bizjournals.com
Wednesday, June 1, 2011 - 7:48am
tags:
Pozen, patents, GSK, migraines, Sun Pharma, Treximet
Positive Data for UCB's Cimzia
Yahoo/Zacks.com
Wednesday, June 1, 2011 - 7:47am
tags:
UCB Pharmaceuticals, Cimzia, Abbott Laboratories, rheumatoid arthritis
Drugmakers Face Patent Cliff Generics
Yahoo/InvestorsBusinessDaily
Wednesday, June 1, 2011 - 7:46am
tags:
patents, generics, GSK, Bristol-Myers Squibb, AstraZeneca, Pfizer, Eli Lilly, Merck, Forest Labs, Teva Pharmaceuticals, Abbott Laboratories
N. American pharma buys drive up M&A prices
Fierce Pharma
Tuesday, May 31, 2011 - 6:01pm
tags:
M&A
6 Prime Biotechs for Short- and Long-Term Gains
Seeking Alpha
Tuesday, May 31, 2011 - 5:59pm
tags:
BioSante, Supergen, Acadia, Rexahn, Aeterna Zentaris, Antares
Teva Settles Neurontin Case With Pfizer on Undisclosed Terms
Bloomberg
Tuesday, May 31, 2011 - 5:57pm
tags:
Pfizer, Teva Pharmaceuticals, settlements, Neurontin
Bacterin International: A Biotech Heading Toward Profitability
Seeking Alpha
Tuesday, May 31, 2011 - 1:56pm
tags:
Bacterin International Holdings
Sanofi's diabetes drug cuts blood sugar, weight-study
Reuters
Tuesday, May 31, 2011 - 1:54pm
tags:
Sanofi, diabetes, Lyxumia
Amarin taps suppliers for 'aggressive' launch
Fierce Pharma
Tuesday, May 31, 2011 - 1:52pm
tags:
AMR101, Amarin, GSK, Lovaza

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.